↓ Skip to main content
What is this page? Embed badge

Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non–muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial

Overview of attention for article published in European Urology, December 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter
18 X users
guideline
1 clinical guideline source

Readers on

mendeley
27 Mendeley
So far, Altmetric has seen 1 Guideline that references this research output.

Bladder-sparing Therapy for Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection

Clinical guideline published by International Bladder Cancer Group (IBCG) on

The International Bladder Cancer Group (IBCG) is a global consortium dedicated to enhancing bladder cancer care through evidence-based guidelines and educational initiatives. By uniting experts, IBCG aims to improve patient outcomes and establish international standards in treatment.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.